Phathom Pharmaceuticals, Inc.
USD10.87
+0.15 (+1.40%)
CEO
Steven L. Basta
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.87
Prev. Close
$10.72
Day Low
$10.34
Day High
$10.94
52W Low
$7.61
52W High
$18.31
Market Cap
$0.87B
Volume
1.09M
| $0.00 |
| 21 May 2026 | Topper James N | director, 10 percent owner: | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | Stenhouse Mark | director | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | FIELDS HEIDI | director | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | COLA MICHAEL F | director | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | KARBE FRANK | director | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | Schroeder Theodore R | director | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | Parikh Asit | director | A-Award | Acquired | 24,122 | $0.00 |
| 21 May 2026 | Parikh Asit | director | M-Exempt | Acquired | 17,500 | $4.95 |